Yiteng pharmaceutical is authorized by syndex pharmaceutical to develop, produce and sell new anticancer drugs exclusively
Time of Update: 2020-04-03
Recently, Yiteng pharmaceutical, a leading professional pharmaceutical company in China, signed a license agreement with syndex pharmaceutical on the new anticancer drug entinostat.
Transfer of new drug technology of danyutongmai granules from Wuzhong pharmaceutical to Lingrui pharmaceutical
Time of Update: 2020-04-03
The transfer of new drug technology is based on the strategic adjustment of the existing product structure of the pharmaceutical group to establish the development direction of antiviral drugs, anti-tumor drugs, immunomodulatory drugs and digestive drugs in the future.
The situation of pharmaceutical industry is grim, how to survive for small and medium-sized pharmaceutical enterprises
Time of Update: 2020-02-17
Pharmaceutical enterprises need core products with characteristics At present, with the implementation of the volume purchase policy, the concentration of the pharmaceutical industry will further improve, and the market competition will become increasingly fierce.
Fund companies intensively investigate the pharmaceutical industry, and the number of these four pharmaceutical companies exceeds 50
Time of Update: 2020-02-14
[pharmaceutical network industry trends] according to industry statistics, between February 3 and February 13, 716 fund companies have investigated 82 listed companies, with 1374
Under the epidemic situation, the pharmaceutical sector continued to be strong, Yisheng pharmaceutical industry rose 7.35
Time of Update: 2020-02-05
On February 4, the Shanghai and Shenzhen stock markets opened lower and went higher today, with market sentiment clearly picking up
As of the closing, the Shanghai index
The opening action of 2020 pharmaceutical industry: a number of pharmaceutical enterprises merge and a number of pharmaceutical enterprises sell assets
Time of Update: 2020-01-15
[trends of pharmaceutical network industry] influenced by policies such as expanding with volume procurement, new medical insurance, consistency evaluation, etc., since
Policy year pharmaceutical enterprises deeply affected
Time of Update: 2020-01-14
Recently, Jiangsu Provincial Drug Administration announced that Yangzhou Pharmaceutical was incorporated by Jiangsu Lianhuan pharmaceutical industry
It is understood
Weigh! LVYE pharmaceutical acquired 1.4 billion famous pharmaceutical companies
Time of Update: 2020-01-07
At present, Shandong Boan is engaged in the development of biological products in China, the United States and the European Union.
Where is the difficulty for the pharmaceutical industry in 2019? Resignation of executives of famous pharmaceutical companies
Time of Update: 2019-12-24
(2019 / 12 / 24) what's the difficulty for China's pharmaceutical industry in 2019? ; four kinds of drugs are facing fierce "containment" due to the outbreak of biological similar
Another famous pharmaceutical company was acquired! Acquisition and transfer or become normal in the pharmaceutical industry
Time of Update: 2019-12-02
[industry trends of pharmaceutical network] on November 30, Nanjing Pharmaceutical Co., Ltd
issued the announcement on the acquisition of 70% equity of Jiangsu Enhua
Pharmaceutical enterprises accelerate the transformation and upgrading, pharmaceutical equipment enterprises can not be absent
Time of Update: 2019-11-29
In addition to truking, the author noted that domestic pharmaceutical equipment enterprises, such as Dong Fulong, have also maintained strategic cooperative relations with pharmaceutical enterprises and jointly committed to the better development of pharmaceutical industry.
How does environmental protection, a compulsory course for pharmaceutical enterprises, affect the pharmaceutical industry
Time of Update: 2019-11-08
Environmental protection tax is conducive to stimulating pharmaceutical enterprises to attach importance to energy conservation and emission reduction, increasing investment in relevant new equipment, and eliminating backward high pollution and high energy consumption equipment.
Pharmaceutical market pattern changes, pharmaceutical equipment industry meets more opportunities and challenges
Time of Update: 2019-08-19
[pharmaceutical network market analysis] with the deepening of medical reform, the promotion of consistency evaluation, the intensive introduction of policies such as "4 + 7
Top 100 pharmaceutical companies in 2019
Time of Update: 2019-08-08
The following figure is a list of the top 100 global pharmaceutical companies from novasecta, a pharmaceutical consulting company.
The pharmaceutical equipment industry lags behind the pharmaceutical industry. How can we make progress
Time of Update: 2019-06-05
With the increasing requirements of pharmaceutical industry in recent years, and the fierce competition in the pharmaceutical equipment market, improving the processing accuracy of pharmaceutical equipment has become the development direction that enterprises have to strive for.
Improve the quality of pharmaceutical products, and put forward new standard requirements for pharmaceutical excipients in Pharmacopoeia 2020
Time of Update: 2019-06-04
Promote the high-quality development of pharmaceutical excipients and help the progress of China's pharmaceutical industry.
Development direction of pharmaceutical intermediates industry
Time of Update: 2019-04-17
1. Improve the technology, save the cost, the process route of pharmaceutical intermediates is long, the reaction steps are many, the use of solvents is large, and the potential of technology improvement is great.
Pharmaceutical intelligence data enterprise version 1.2 & Pharmaceutical intelligence data app2.2 strong new
Time of Update: 2019-04-16
You can quickly filter out the data information you want to retrieve through the search hot spots of "consistency evaluation, deemed to pass consistency evaluation"; For the more convenient app, a user guide video is launched for business users.
Pharmaceutical enterprises aim at the pharmaceutical prospect of industrial marijuana and lay out 10 billion "emerging industries
Time of Update: 2019-04-03
Experts said that there are many market opportunities in the market supply and deep processing of industrial marijuana, especially in the context of the sharp price reduction of drugs, many pharmaceutical enterprises are looking for new business units.
Sihuan pharmaceutical acquires 27.82% equity of Duoduo pharmaceutical
Time of Update: 2019-03-26
Through consultation between Sihuan pharmaceutical and Heilongjiang Jiajian enterprise management consulting service partnership (hereinafter referred to as Heilongjiang Jiajian), Sihuan pharmaceutical transferred its 9.56% equity in Duoduo pharmaceutical industry to Heilongjiang Jiajian with 84.74 million yuan.